THE-630
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for THE-630, covering 2024-06-05 to 2024-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) [Phase 1, Phase 2]